Investor Relations

Presentations

Receive E-mail AlertsE-mail Alerts
DateTitle
11/14/17
Download Documentation November Investor Conference Presentation
11/07/17
Download Documentation Vanda Pharmaceuticals Q3 2017 Earnings Call Transcript
11/07/17
Download Documentation Q3 2017 Vanda Pharmaceuticals Inc. Earnings Conference Call
10/11/17
Download Documentation 2017 Corporate Presentation
10/02/17
Download Documentation Tradipitant Improves Worst Itch and Disease Severity in Patients with Chronic Pruritus Related to Atopic Dermatitis, 9th World Congress of Itch, October 16, 2017
09/14/17
Download Documentation Vanda Tradipitant Results Presentation
09/14/17
Download Documentation Vanda Tradipitant Results Call - Transcript
09/14/17
Download Documentation Vanda Tradipitant Results Call
08/02/17
Download Documentation Vanda Pharmaceuticals Q2 2017 Earnings Call Transcript
05/02/17
Download Documentation Vanda Pharmaceuticals Q1 2017 Earnings Call Transcript
02/15/17
Download Documentation Vanda Pharmaceuticals Q4 2016 Earnings Call Transcript
11/02/16
Download Documentation Vanda Pharmaceuticals Q3 2016 Earnings Call Transcript
07/27/16
Download Documentation Vanda Pharmaceuticals Q2 2016 Earnings Call Transcript
05/04/16
Download Documentation Vanda Pharmaceuticals Q1 2016 Earnings Call Transcript
06/24/13
Download Documentation ENDO 2013 - SET study / tasimelteon for Non-24-Hour Disorder
06/24/13
Download Documentation ENDO 2013 - RESET study / tasimelteon for Non-24-Hour Disorder
01/23/13
Download Documentation Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder - Conference Call Transcript
12/18/12
Download Documentation Vanda Pharmaceuticals Inc. Announces Positive Phase III Results For Tasimelteon In The Treatment Of Non-24-Hour Disorder- Conference Call Transcript
06/11/12
Download Documentation Seventy Percent of Totally Blind People with Sleep Complaints Are Not Entrained to the 24 Hour Clock
06/11/12
Download Documentation Pleiomorphic Expression of N24HSWD in the Totally Blind
06/11/12
Download Documentation Significant Sleep Impairment in Totally Blind Individuals with N24HSWD
06/11/12
Download Documentation Timing and Duration of Nap Episodes are Coincident with Melatonin Acrophase
06/11/12
Download Documentation A National Registry of Totally Blind Individuals with Sleep-Wake Complaints
Get help downloading or viewing the above file types
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy